Literature DB >> 26400871

Mobile Phone Ownership and Endorsement of "mHealth" Among People With Psychosis: A Meta-analysis of Cross-sectional Studies.

Joseph Firth1, Jack Cotter2, John Torous3, Sandra Bucci4, Josh A Firth5, Alison R Yung6.   

Abstract

There is currently growing interest in using mobile phones to support the treatment of psychotic disorders, such as schizophrenia. However, the widespread implementation of these interventions will ultimately depend upon patients' access to mobile devices and their willingness to engage with mobile health ("mHealth"). Thus, we conducted a systematic review and meta-analysis to assess mobile phone ownership and interest in mHealth among patients with psychosis. An electronic search of Ovid MEDLINE, Embase, PsycINFO, CENTRAL, AMED, Health Technology Assessment Database, and Health Management Information Consortium Database was conducted, using search terms synonymous with mobile phones and psychotic disorders. The initial literature search yielded 2572 results. Fifteen studies matched eligibility criteria, reporting data from 12 independent samples of psychiatric patients (n = 3227). Data pertaining to mobile phone ownership, usage, and opinions on mHealth among patients with psychotic disorders were extracted from these studies, and meta-analytic techniques were applied. The overall mobile phone ownership rate was 66.4% (95% CI = 54.1%-77.6%). However, we found strong statistical evidence that mobile phone ownership has been significantly increasing since 2007, and the rate among patients surveyed in the last 2 years was 81.4% (n = 454). Furthermore, in surveys of mHealth acceptability, the majority of patients responded in favor of using mobile phones to enhance contact with services and support self-management. Considering the increasing availability of mobile phones and the broad acceptability of mHealth among patients, there is now a need to develop and evaluate mHealth interventions to enhance healthcare services for people with psychosis.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cell phone; e-health; psychotic disorder; schizophrenia; smartphone; technology

Mesh:

Year:  2015        PMID: 26400871      PMCID: PMC4753601          DOI: 10.1093/schbul/sbv132

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  39 in total

1.  Mobile technologies in the study, assessment, and treatment of schizophrenia.

Authors:  Dror Ben-Zeev
Journal:  Schizophr Bull       Date:  2012-01-10       Impact factor: 9.306

2.  Text message reminders of appointments: a pilot intervention at four community mental health clinics in London.

Authors:  Hannah Sims; Harpreet Sanghara; Daniel Hayes; Symon Wandiembe; Matthew Finch; Hanne Jakobsen; Elias Tsakanikos; Chike Ify Okocha; Eugenia Kravariti
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

3.  Technology Access and Use Among Young Adults With a First Episode of Psychosis.

Authors:  Shalini Lal; Jennifer Dell'Elce; Ashok K Malla
Journal:  Psychiatr Serv       Date:  2015-07       Impact factor: 3.084

Review 4.  Mobile health (mHealth) for mental health in Asia: objectives, strategies, and limitations.

Authors:  Rachel M Brian; Dror Ben-Zeev
Journal:  Asian J Psychiatr       Date:  2014-04-27

Review 5.  Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.

Authors:  Tara Horvath; Hana Azman; Gail E Kennedy; George W Rutherford
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 6.  Mobile phone messaging for communicating results of medical investigations.

Authors:  Ipek Gurol-Urganci; Thyra de Jongh; Vlasta Vodopivec-Jamsek; Josip Car; Rifat Atun
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

7.  Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy.

Authors:  Jonathan B Bricker; Kristin E Mull; Julie A Kientz; Roger Vilardaga; Laina D Mercer; Katrina J Akioka; Jaimee L Heffner
Journal:  Drug Alcohol Depend       Date:  2014-07-17       Impact factor: 4.492

8.  Integrating mobile-phone based assessment for psychosis into people's everyday lives and clinical care: a qualitative study.

Authors:  Jasper E Palmier-Claus; Anne Rogers; John Ainsworth; Matt Machin; Christine Barrowclough; Louise Laverty; Emma Barkus; Shitij Kapur; Til Wykes; Shôn W Lewis
Journal:  BMC Psychiatry       Date:  2013-01-23       Impact factor: 3.630

9.  The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application.

Authors:  Jasper E Palmier-Claus; John Ainsworth; Matthew Machin; Cristine Barrowclough; Graham Dunn; Emma Barkus; Anne Rogers; Til Wykes; Shitij Kapur; Iain Buchan; Emma Salter; Shôn W Lewis
Journal:  BMC Psychiatry       Date:  2012-10-17       Impact factor: 3.630

10.  Patient Smartphone Ownership and Interest in Mobile Apps to Monitor Symptoms of Mental Health Conditions: A Survey in Four Geographically Distinct Psychiatric Clinics.

Authors:  John Torous; Steven Richard Chan; Shih Yee-Marie Tan; Jacob Behrens; Ian Mathew; Erich J Conrad; Ladson Hinton; Peter Yellowlees; Matcheri Keshavan
Journal:  JMIR Ment Health       Date:  2014-12-23
View more
  124 in total

Review 1.  Can Smartphone Apps Assist People with Serious Mental Illness in Taking Medications as Prescribed?

Authors:  Cynthia L Bianco; Amanda L Myers; Stephen Smagula; Karen L Fortuna
Journal:  Sleep Med Clin       Date:  2020-12-07

2.  A Survey of Online and Mobile Technology Use at Peer Support Agencies.

Authors:  Kelly A Aschbrenner; John A Naslund; Thomas Grinley; John Carlo M Bienvenida; Stephen J Bartels; Mary Brunette
Journal:  Psychiatr Q       Date:  2018-09

3.  Use of Smartphones, Computers and Social Media Among People with SMI: Opportunity for Intervention.

Authors:  M F Brunette; E Achtyes; S Pratt; K Stilwell; M Opperman; S Guarino; F Kay-Lambkin
Journal:  Community Ment Health J       Date:  2019-06-08

Review 4.  Digital Technologies in the Treatment of Anxiety: Recent Innovations and Future Directions.

Authors:  Joseph Firth; John Torous; Rebekah Carney; Jill Newby; Theodore D Cosco; Helen Christensen; Jerome Sarris
Journal:  Curr Psychiatry Rep       Date:  2018-05-19       Impact factor: 5.285

5.  Single-Session Mobile-Augmented Intervention in Serious Mental Illness: A Three-Arm Randomized Controlled Trial.

Authors:  Colin A Depp; Dimitri Perivoliotis; Jason Holden; Jennifer Dorr; Eric L Granholm
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

Review 6.  Health behavior models for informing digital technology interventions for individuals with mental illness.

Authors:  John A Naslund; Kelly A Aschbrenner; Sunny Jung Kim; Gregory J McHugo; Jürgen Unützer; Stephen J Bartels; Lisa A Marsch
Journal:  Psychiatr Rehabil J       Date:  2017-02-09

7.  Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.

Authors:  Benjamin Buck; Emily Scherer; Rachel Brian; Rui Wang; Weichen Wang; Andrew Campbell; Tanzeem Choudhury; Marta Hauser; John M Kane; Dror Ben-Zeev
Journal:  Schizophr Res       Date:  2019-03-30       Impact factor: 4.939

8.  Peer Support: a Human Factor to Enhance Engagement in Digital Health Behavior Change Interventions.

Authors:  Karen L Fortuna; Jessica M Brooks; Emre Umucu; Robert Walker; Phillip I Chow
Journal:  J Technol Behav Sci       Date:  2019-05-29

9.  Wearable Devices and Smartphones for Activity Tracking Among People with Serious Mental Illness.

Authors:  John A Naslund; Kelly A Aschbrenner; Stephen J Bartels
Journal:  Ment Health Phys Act       Date:  2016-03

10.  Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.

Authors:  Bernadette A Cullen; Katrina Rodriguez; William W Eaton; Ramin Mojtabai; Tara Von Mach; Michele L Ybarra
Journal:  Psychiatry Res       Date:  2020-07-29       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.